肺癌、头颈癌与食管癌临床靶区:病理测量与复发分析的启示
本文综述肺癌、头颈癌和食管癌临床靶区定义的现状,指出临床靶区(CTV)仍多依赖临床经验与机构惯例而非患者个体化。亚临床病灶在现有影像中不可见,只能通过手术标本组织病理学测量和放疗后局部区域复发分析间接确定其范围。
要点
- 临床靶区(CTV)定义进展有限,多凭临床经验与机构惯例。
- 亚临床病灶影像不可见,需间接方法确定其范围。
- 组织病理学测量与复发分析是确定CTV的两种策略。
核心结论
- 放疗靶区研究中,大体肿瘤体积(GTV)定位已因影像进步而更精确,但临床靶区(CTV)的演变非常有限。
研究设计与样本
- 本文为综述,汇总了通过手术切除标本组织病理学测量和放疗后局部区域复发分析来界定亚临床病灶范围的两种策略。
主要发现
- 临床靶区(CTV)更多依据临床医生经验和机构惯例定义,而非基于患者个体情况。
- 亚临床病灶在现有医学影像中不可见,其发生率和范围只能通过间接手段确定。
临床怎么用
- 可借助手术标本病理测量和放疗后复发模式分析,辅助个体化界定肺癌、头颈癌和食管癌的临床靶区(CTV)。
局限性
- 亚临床病灶在现有影像中不可见,其范围只能通过间接手段推断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Radiotherapy research has achieved remarkable progress in target volume definition. Advances in medical imaging facilitate more precise localization of the gross tumor volume, alongside a more detailed understanding of the geometric uncertainties associated with treatment delivery that has enabled robust safety margins to be customized to the specific treatment scenario at hand. By contrast, the clinical target volume, meant to encompass gross tumor, as well as, adjacent sub-clinical disease, has evolved very little. It is more often defined by clinician experience and institutional convention than on a patient-specific basis. This disparity arises from the inherent invisibility of sub-clinical disease in current medical imaging. Its incidence and expanse can only be ascertained via indirect means. This article reviews two such strategies: histopathological measurements on resection specimen and analyses of locoregional recurrences after radiotherapy.
引用
- Apolle R, Rehm M, Bortfeld T, et al. The clinical target volume in lung, head-and-neck, and esophageal cancer: Lessons from pathological measurement and recurrence analysis. Clin Transl Radiat Oncol. 2017. PMID: 29658006. doi:10.1016/j.ctro.2017.01.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。